Premier Pharma 1 LP — Form D
Premier Pharma 1 LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2016-12-07. Industry: Pooled Investment Fund.
Offering
- Filed: 2016-12-07
- Form: D
- Accession: 0000950103-16-018563
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Minimum investment: $500K
- Security types: fund interests
- SEC file number: 021-275824
Issuer
- Name: Premier Pharma 1 LP
- CIK: 0001691681
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 522 FIFTH AVENUE, 13TH FLOOR, NEW YORK, NY, 10036
- Phone: 212-296-6000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jeremy Beal | Director | New York, NY |
| James Bruno | Director | New York, NY |
| Michael Korn | Director | New York, NY |
| - Morgan Stanley Strategies II LLC | Executive Officer | NEW YORK, NY |
More